Sri Lanka, Oct. 15 -- ra Eliya and the other a new housing estate out of Colombo. One place is filling up rapidly while the other is steadily emptying. This divergence has a name and it is not ...

ISM9546 is an investigational, orally bioavailable, peripherally restricted VAV1 (Vav guanine nucleotide exchange factor 1) molecular glue degrader designed to target and degrade VAV1, a protein ...

ISM9546 marks Insilico Medicine's 35th preclinical candidate (PCC) nominated since 2021 and its 11th PCC within the first 10 ...

The UN projects global growth of 2.6% in 2026 as energy shocks and trade barriers weigh on economies, while Asia drives much ...

Objective Systemic lupus erythematosus Prospective Observational Cohort Study (SPOCS) was a prospective observational study ...

A study of 984 rheumatoid arthritis patients finds that the Prognostic Nutritional Index, a simple blood-based score ...

The desire to reduce targeted DMARD dosing is certainly admirable. These products are expensive and come with side effects.

In this article, we have organized the selection of 14 molecular targeted drugs for rheumatoid arthritis (9 biologics and 5 ...

The Schwab Trading Activity Index™ (STAX) increased to 58.92 in September, up from its score of 57.50 in August. The only index of its kind, the STAX is a proprietary, behavior-based index that ...

A T-cell engager, blinatumomab, delivered in low doses may be beneficial in reducing disease activity and depleting synovial ...

PROPEL will test imeroprubart, an investigational FcRn blocker, against placebo in adults with mild to severe generalized ...

Oral presentation highlighting updated clinical data from at least 20 patients with refractory rheumatoid arthritis (RA), 11 patients with Sjögren disease (SjD) and at least five patients with ...